William Blair & Company
ABPI

William Blair & Company’s Accentia Biopharmaceuticals ABPI Stock Holding History

William Blair & Company’s Portfolio ABPI Stock Details ABPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,500
Closed – – 1622
2017
Q2 		$0 Hold
17,500
– – ﹤0.01% 1718
2017
Q1 		$0 Hold
17,500
– – ﹤0.01% 1551
2016
Q4 		$0 Hold
17,500
– – ﹤0.01% 1512
2016
Q3 		$0 Hold
17,500
– – ﹤0.01% 1355
2016
Q2 		$0 Hold
17,500
– – ﹤0.01% 1324
2016
Q1 		$0 Buy
+17,500
New – ﹤0.01% 1290

William Blair & Company's ABPI Position: Q3 2017 in Review

William Blair & Company sold out of Accentia Biopharmaceuticals (ABPI) in Q3 2017, closing a stake of 17,500 shares.

William Blair & Company first reported a position in ABPI in Q1 2016 and held it in 6 quarters. The position peaked at $0 in Q2 2017. 0 funds tracked by Wall St. Rank hold ABPI as of Q3 2017.

  • William Blair & Company reported no remaining Accentia Biopharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • William Blair & Company sold 17,500 Accentia Biopharmaceuticals shares in Q3 2017.
  • William Blair & Company first reported a position in Accentia Biopharmaceuticals in Q1 2016 and held it in 6 quarters.
  • William Blair & Company's Accentia Biopharmaceuticals position peaked at $0 in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Accentia Biopharmaceuticals as of Q3 2017.

Based on William Blair & Company's 13F filing for Q3 2017, filed 13 Nov 2017.